PuraMed BioScience Explores the Development of Hemp and THC-Free Cannabis Formulations to Expand Its Product Line

posted in: US Hemp Co 0

Schofield, WI (PRWEB) March 24, 2014

PuraMed BioScience®, Inc., (OTCBB:PMBS), a researcher, developer, and marketer of over-the-counter (OTC) medicinal and healthcare products, confirmed today that it is seriously exploring the development of cannabinoid and hemp-based formulations to expand its natural and homeopathic product line.

PuraMed BioScience initially intends to develop and manufacture hemp and THC-free formulations that create medicinal compounds that don’t produce the “high” associated with cannabis containing THC. Scientific research has shown that cannabinoids can be formulated to effectively treat conditions such as multiple sclerosis, Crohn’s disease, pain, neurodegenerative disorders, epilepsy, arthritis and combat the effects of cancer chemotherapy.

“Integrating cannabinoid-based medications into our product line makes sense with what we are already doing,” said Russell Mitchell, CEO of PuraMed BioScience. “Cannabis has been used medicinally for centuries. It has only been in the last 100 years that its schedule 1 drug status and the abuse of this product for non-medicinal purposes has detracted from its medicinal benefits. Medical journal publication sites list many medical articles that report cannabinoids provide a viable treatment to neurologic problems, inflammatory diseases, and pain.

“Due to recent changes in the legality and availability of cannabinoids, we believe the future looks extremely bright for the development of highly effective and safe treatments incorporating these hemp derived compounds,” said Mitchell.

Scientific evidence continues to grow as to the effectiveness and safety of certain cannabinoids used to treat a number of disease states. In his article, ‘I am doubling down’ on medical marijuana, published on CNN Health, Dr. Sanjay Gupta, practicing neurosurgeon and CNN Chief Medical Correspondent, confirms his previous article apologizing for dismissing the plant’s potential.

Dr. Gupta has seen first-hand the benefit of this substance in the lives of people as shown in his documentaries Weed and Weed2, which recently aired on CNN. During his documentaries, Dr. Gupta stated that, unlike some prescription pain relievers, no one has died from an overdose of cannabis.

Even the United States government holds patents on cannabis-based formulations.

PuraMed BioScience has been investigating this market for nearly two years and found that cannabinoids offer a structure and function that fits ideally with several of its existing technologies. “We have been following the studies that currently are being conducted in Israel,” said Mitchell.

The company has researched the potential efficacy of cannabinoid-based pain treatment for patients with rheumatoid arthritis and chronic back pain and found that there was evidence of a high probability of success. PuraMed believes that a combination of cannabinoids with other natural compounds can provide superior results while avoiding the often severe side effects of many of the prescription treatments.

“The results of our preliminary research combined with the fact that the US cannabis market is expected to grow to over $ 10 billion by 2018, are strong reasons to aggressively develop a cannabis and hemp-based product line,” said Mitchell. “Development of these products will continue our mission of providing safe, effective products that use natural ingredients.

“We are particularly interested in the development of a formulation that will help veterans who are suffering the effects of Post Traumatic Stress Disorder (PTSD),” said Mitchell. “An effective PTSD formulation in addition to our LipiGesic® M migraine product would allow us to provide veterans with two effective medications to relieve these debilitating conditions.”

According to reports, on March 14, 2014, Suzanne Sisley, a lead researcher at the University of Arizona received approval from the Public Health Service, a branch of the US Department of Health & Human Services to research medical marijuana’s effectiveness in the treatment of PTSD. This was the second of three approvals necessary to conduct the research. The research has been approved by the US Food and Drug Administration (FDA) and is awaiting approval from the Drug Enforcement Administration (DEA).

At this point in time, six states approve the use of medical cannabis for PTSD.

PuraMed BioScience intends to become a leader in the cannabinoid-based medicine market utilizing its proven ability to develop and produce highly effective plant based medicines. The company has historically used scientific and clinical studies to prove the efficacy and safety of its products. PMBS expects to lead the way in conducting the same level of validated science for any product that contains cannabinoids.

“We’ve produced a highly effective acute migraine medication using feverfew and ginger that has been clinically tested and found to provide efficacies that perform better than its prescription counterparts,” said Mitchell. “We have faced an uphill battle with the adoption of homeopathic drugs in the mainstream, but we see that changing as well.”

In the March 24, 2014 issue of Woman’s World, LipiGesic® M is featured in an article entitled, “No more migraine pain!” The combination of feverfew and ginger was a treatment for migraine was also mentioned in “Nature’s First Aid Kit” which appeared in the February 2014 issue of O The Oprah Magazine.

“Publication in these magazines proves that the public is beginning to embrace the idea of “natural and safe” medications made with homeopathic formulations,” said Mitchell. “As more of the public embraces natural medicinal products, we will continue to provide formulations that operate with the highest level of efficacy and safety, which will allow people to choose a natural alternative without compromising treatment outcomes.”

About LipiGesic M:

Results of a double-blind, placebo-controlled clinical trial for LipiGesic®M show LipiGesic M is a highly effective treatment for acute migraine. The study was published in the July 2011 issue of the top-tier medical journal, Headache: The Journal of Head and Face Pain. In addition to LipiGesic M, the Company also has plans to launch LipiGesic® H, tension headache remedy, as well as LipiGesic® PM, a remedy for insomnia and other sleep disorders.

Forward-Looking Statements:

This news release contains forward-looking statements regarding PuraMed BioScience, Inc., and its future business plans, which statements involve known and unknown risks and uncertainties. Such risks and uncertainties may cause actual results and future achievements of PuraMed BioScience to be materially different from those implied by these forward-looking statements. PuraMed BioScience has and undertakes no obligation to provide public updates and revisions to these forward-looking statements to reflect any changes in its expectations of future events.

Contact:

PuraMed BioScience, Inc.

Russell Mitchell, Chairman and CEO

715-359-6373

rmitchell(at)PuramedBioScience(dot)com

http://www.PuramedBioScience.com







HempLifeToday Announces Development of AquazALL, a New Bottled Alaskan …

HempLifeToday Announces Development of AquazALL, a New Bottled Alaskan …
HempLifeToday.com™ focuses on the exciting and dynamic new thinking in the world today that recognizes the important health and life enriching enhancement that CBD Oil from the Hemp plant can bring. HempLifeToday.com™ has developed two award …
Read more on Digital Journal

Legal Marijuana in Arizona? Pick Your Ballot Measure
Among the other proposed ballot initiatives is one asking for the regulation and cultivation of industrial hemp by people registered by the state. Another calls for the re-legalization of all drugs, including marijuana, heroin, cocaine and LSD; along …
Read more on Arizona Public Media

Engage Mobile Solidifies its Role as Leader in Mobile Strategy and Mobile App Development

posted in: US Hemp Co 0


Kansas City, MO (PRWEB) July 01, 2014

After making its mark on the Kansas City landscape with the news that it would be one of the firms to beta test Google Inc.’s groundbreaking technology – Google Glass – in 2013, Engage Mobile Solutions continues to develop solutions for clients that transform their businesses and industries.

In addition to being involved in one of the most dynamic industries in the world right now –Engage Mobile is rapidly growing its revenue and number of employees as well as winning multiple awards and accolades in the past year. The company’s success is simply remarkable.

When it comes to the bottom line, the numbers speak for themselves. Engage Mobile quadrupled its revenue in 2013, says president Matthew Barksdale. He expects revenue will more than double in 2014.

Add to that the honors the company has received in the last year, and it’s hard not to take notice. Among the firm’s recent accomplishments:

Selected as one of the 20 “Most Promising Enterprise Mobility Companies in the U.S.”
Named one of Kansas City’s top companies with fewer than 25 employees
Chosen as a top-three finalist for the 2014 Appy Awards for its Vs. Football app in the category of Games: Action/Arcade/Sports

On top of company achievements, both of Engage Mobile’s top leaders – CEO Darrin Clawson and president Matthew Barksdale – have been recognized in the Kansas City community in recent months for their innovative ideas and unique business strategy.

Engage Mobile founder and CEO Clawson was chosen for Kansas City’s elite Helzberg Entrepreneurial Mentoring Program. HEMP is comprised of some of the Midwest’s top forward-thinking business leaders.

As president, Barksdale was recently selected as part of the KC Chamber’s Access for Entrepreneurs program, which touts its members as “Kansas City’s most dynamic entrepreneurs.” The group strives to capture the energy and innovation behind local businesses while encouraging civic leadership.

Beneath it all, Engage continues quietly adding clients and securing some of the top mobile strategy and development talent in the country.

“We have assembled a team of some of the best mobile minds in the country,” Clawson says. “Creating one of the top teams in the country allows us to develop complex solutions that significantly drive the success of our clients. We are not just about building mobile apps – we are about helping our clients transform their business through the adoption of mobile technology.”

In addition to building mobile apps for clients, Engage Mobile took the helm and launched its own cutting-edge gaming app, Vs. Football, just in time for gridiron season last fall.

The freemium app, which had over 1 million plays called in its first 9 months, features old-school, smash mouth-strategy football. Users play against their friends and are able to act as the coach and call plays from their own digital playbook. In the game, Engage Mobile developers introduced a revolutionary technology called the “outcome decision engine” which instantly analyzes the particular offensive/defensive play combination players have selected and determines the most likely outcomes based on complex algorithms developed by high school and college football coaches.

This innovative gaming app got Engage Mobile its finalist nomination for the 2014 Appy Awards, which acknowledge creativity and excellence in app design.

And the Google Glass testing that helped put Engage Mobile on the map last year? It’s gotten faster and more innovative. In the past year, Engage Mobile has used Google Glass to capture first-hand views of playful penguins at the Kansas City Zoo, put race car fans in the driver’s seat on a test run at the Indianapolis Motor Speedway, and immersed classical music lovers in melodic interludes as part of the orchestra at the Kansas City Symphony.

Engage Mobile stands poised to continue its remarkable growth.

“We are just getting started,” says vice president Steve Timperley. “In the second half of 2014 we will be launching enterprise mobile apps for several major public and private companies that will impact industries ranging from health to retail. Our experience is rapidly compounding – innovation leads to more innovation, success leads to more success. It is a very exciting time.”

About Engage Mobile Solutions

Engage Mobile Solutions is an award-winning mobile app and mobile software development company with a focus on mobile strategy and mobile marketing. Based in Kansas City, Mo., the firm helps companies leverage mobile technology and drive profitability through increasing revenue, decreasing costs, and managing risk. The company was named one of the “Most Promising Enterprise Mobility Companies in the United states” by CIO Review, chosen as one of the “Top Companies in Kansas City With Under 25 Employees” by Thinking Bigger Business Media, and has been selected a finalist for the 2014 Appy Awards by MediaPost Communications. For more information about Engage Mobile Solutions, visit http://www.engagemobile.com or contact Matthew Barksdale at mbarksdale(at)engagemobile(dot)com.